Effect of chronic administration of clonidine, propranolol and alpha-methyldopa on extensibility and biochemical properties of the veins in renal and spontaneous hypertension.
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001834:Body Water / Q000378:metabolism; D003000:Clonidine / Q000494:pharmacology; D004247:DNA / Q000378:metabolism; D004548:Elasticity; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006973:Hypertension / Q000503:physiopathology*; D006977:Hypertension, Renal / Q000503:physiopathology*; D006978:Hypertension, Renovascular / Q000503:physiopathology*; D008297:Male; D008750:Methyldopa / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism; D051381:Rats; D014680:Veins / Q000187:drug effects* / Q000378:metabolism
D000959:Antihypertensive Agents; D011506:Proteins; D010643:Phenoxybenzamine; D008750:Methyldopa; D004247:DNA; D011433:Propranolol; D003000:Clonidine; D010646:Phentolamine